Innoviva Inc (INVA)

Return on equity (ROE)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	23,392	64,591	145,424	181,389	179,722	49,877	233,354	233,013	213,921	292,580	99,495	187,504	265,854	309,412	265,192	253,088	224,402	216,448	228,039	188,935
Total stockholders’ equity	US$ in thousands	1,054,680	668,542	665,515	703,681	674,955	627,493	555,087	561,493	565,788	641,368	388,337	386,642	414,743	402,811	329,780	634,461	539,912	485,556	456,907	379,543
ROE		2.22%	9.66%	21.85%	25.78%	26.63%	7.95%	42.04%	41.50%	37.81%	45.62%	25.62%	48.50%	64.10%	76.81%	80.41%	39.89%	41.56%	44.58%	49.91%	49.78%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $23,392K ÷ $1,054,680K
= 2.22%

Innoviva Inc's return on equity (ROE) has shown fluctuating trends over the period from March 31, 2020, to December 31, 2024. The ROE started at a relatively high level of 49.78% in March 2020 and maintained strong performance through the first half of 2020, reaching 49.91% in June 2020.

However, there was a slight decline in ROE in the latter half of 2020, dropping to 41.56% by December 2020. This decreasing trend continued into 2021, with ROE falling to 39.89% by March 2021.

A significant improvement was seen in the second quarter of 2021, where ROE surged to 80.41%, highlighting a notable recovery in profitability. This strong performance was sustained in the following quarters, with ROE remaining above 60% until June 2022.

From the third quarter of 2022 onwards, there was a notable decline in ROE, dropping to as low as 2.22% by December 31, 2024. This downward trend indicates a possible decrease in profitability and efficiency in utilizing shareholders' equity.

In summary, Innoviva Inc exhibited variable ROE performance over the analyzed period, with periods of high profitability alternating with periods of decline. It is important for investors and stakeholders to monitor these trends closely to assess the company's financial health and operational efficiency.